Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (323)
  2. Meeting Abstract (280)
  3. Review (19)
  4. Editorial (10)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (655)
  2. Center for Hematologic Malignancies (655)
  3. Department of Medicine (655)
  4. Hematologic Malignancies, Division of (655)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (118)
  3. Jae Park (81)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (274)
  2. Journal of Clinical Oncology (41)
  3. Blood Advances (27)
  4. Leukemia Research (27)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (25)

More Publications

Publishers
  1. American Society of Hematology (301)
  2. Elsevier Inc. (44)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (655)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Immunotherapy for acute myeloid leukemia: From allogeneic stem cell transplant to novel therapeutics
    Review

    Knorr, D. A.; Goldberg, A. D.; Stein, E. M.; Tallman, M. S.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes
    Journal Article

    Saygin, C.; Kishtagari, A.; Cassaday, R. D.; Reizine, N.; Yurkiewicz, I.; Liedtke, M.; Stock, W.; Larson, R. A.; Levine, R. L.; Tallman, M. S.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Asciminib in chronic myeloid leukemia after ABL kinase inhibitor failure
    Journal Article

    Hughes, T. P.; Mauro, M. J.; Cortes, J. E.; Minami, H.; Rea, D.; DeAngelo, D. J.; Breccia, M.; Goh, Y. T.; Talpaz, M.; Hochhaus, A.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Acute promyelocytic leukemia (APL): Remaining challenges towards a cure for all
    Review

    Stahl, M.; Tallman, M. S.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor
    Journal Article

    Nieborowska-Skorska, M.; Paietta, E. M.; Levine, R. L.; Fernandez, H. F.; Tallman, M. S.; Litzow, M. R.; Skorski, T.
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
    Journal Article

    Pollyea, D. A.; Tallman, M. S.; de Botton, S.; Kantarjian, H. M.; Collins, R.; Stein, A. S.; Frattini, M. G.; Xu, Q.; Tosolini, A.; See, W. L.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): An alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study
    Journal Article

    Ustun, C.; Le-Rademacher, J.; Wang, H. L.; Othus, M.; Sun, Z.; Major, B.; Zhang, M. J.; Storrick, E.; Lafky, J. M.; Chow, S.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation in the treatment of adult acute lymphoblastic leukemia: Updated 2019 evidence-based review from The American Society for Transplantation and Cellular Therapy
    Guidelines

    DeFilipp, Z.; Advani, A. S.; Bachanova, V.; Cassaday, R. D.; Deangelo, D. J.; Kebriaei, P.; Rowe, J. M.; Seftel, M. D.; Stock, W.; Tallman, M. S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab followed by alemtuzumab for relapsed or refractory chronic lymphocytic leukemia: A phase 2 trial of the ECOG-ACRIN Cancer Research Group (E2903)
    Journal Article

    Kempin, S.; Sun, Z.; Kay, N. E.; Paietta, E. M.; Mazza, J. J.; Ketterling, R. P.; Frankfurt, O.; Claxton, D. F.; Saltzman, J. N.; Srkalovic, G.; more...
    Acta Haematologica (2019)

    Fulltext@MSK | Save